Terms: = Endocrine gland cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb
53 results:
1. myb/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma.
Cheng L; Deng X; Le Y
Endokrynol Pol; 2024; 75(1):27-34. PubMed ID: 38497387
[TBL] [Abstract] [Full Text] [Related]
2. Recurrent GATA3 P409Afs*99 Frameshift Extension Mutations in Sweat-gland Carcinoma With Neuroendocrine Differentiation.
Goto K; Kiniwa Y; Kukita Y; Ohe S; Hiraki T; Hishima T; Takai T; Honma K
Am J Surg Pathol; 2024 May; 48(5):528-537. PubMed ID: 38353459
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models.
Miao T; Symonds A; Hickman OJ; Wu D; Wang P; Lemoine N; Wang Y; Linardopoulos S; Halldén G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279262
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA
Wang J; Han Y; Zhang T; Li J; Xu B
Front Biosci (Landmark Ed); 2023 Oct; 28(10):270. PubMed ID: 37919051
[TBL] [Abstract] [Full Text] [Related]
5. A Comprehensive Analysis of Prognostic Indicators in Serous Ovarian cancer Based on Leukocyte Migration and Immune Microenvironment.
Pan J; Chen X; Yang L; Song Y; Liu J; Li L; Lin Y; Tang L; Qiu S; Xu Q
Front Biosci (Landmark Ed); 2023 Jun; 28(6):130. PubMed ID: 37395023
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA-1252-5p, regulated by myb, inhibits invasion and epithelial-mesenchymal transition of pancreatic cancer cells by targeting NEDD9.
Xue Y; Wu T; Sheng Y; Zhong Y; Hu B; Bao C
Aging (Albany NY); 2021 Jul; 13(14):18924-18945. PubMed ID: 34314382
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic significance and race-specific prognostic association of myb overexpression in ovarian cancer.
Miree O; Srivastava SK; Khan MA; Sameeta F; Acharya S; Ndetan H; Singh KP; Hertweck KL; Dasgupta S; da Silva LM; Rocconi RP; Carter JE; Singh S; Singh AP
Sci Rep; 2021 Jun; 11(1):12901. PubMed ID: 34145334
[TBL] [Abstract] [Full Text] [Related]
8. Extracellular vesicle-encapsulated microRNA-424 exerts inhibitory function in ovarian cancer by targeting myb.
Li P; Xin H; Lu L
J Transl Med; 2021 Jan; 19(1):4. PubMed ID: 33407591
[TBL] [Abstract] [Full Text] [Related]
9. Primary Pituitary Adenoid Cystic Carcinoma: A Rare Salivary gland-Like Tumor in the Sella.
Sakata K; Ono T; Koga M; Kikuchi J; Komaki S; Akiba J; Ogo E; Sugita Y; Umeno H; Morioka M
Head Neck Pathol; 2021 Dec; 15(4):1289-1298. PubMed ID: 33398687
[TBL] [Abstract] [Full Text] [Related]
10. Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
Dolezal JM; Trzcinska A; Liao CY; Kochanny S; Blair E; Agrawal N; Keutgen XM; Angelos P; Cipriani NA; Pearson AT
Mod Pathol; 2021 May; 34(5):862-874. PubMed ID: 33299111
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptome sequencing identifies genes associated with invasion of ovarian cancer.
Peng X; Yu M; Chen J
J Int Med Res; 2020 Sep; 48(9):300060520950912. PubMed ID: 32878513
[TBL] [Abstract] [Full Text] [Related]
12. Regulation of myb mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis.
Zhang XY; Li YF; Ma H; Gao YH
Sci Rep; 2020 Apr; 10(1):6893. PubMed ID: 32327705
[TBL] [Abstract] [Full Text] [Related]
13. Proteomic Analysis of myb-Regulated Secretome Identifies Functional Pathways and Biomarkers: Potential Pathobiological and Clinical Implications.
Zubair H; Patel GK; Khan MA; Azim S; Zubair A; Singh S; Srivastava SK; Singh AP
J Proteome Res; 2020 Feb; 19(2):794-804. PubMed ID: 31928012
[TBL] [Abstract] [Full Text] [Related]
14. MicroRNA-150-5p promotes cell motility by inhibiting c-myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
Tung CH; Kuo LW; Huang MF; Wu YY; Tsai YT; Wu JE; Hsu KF; Chen YL; Hong TM
Oncogene; 2020 Jan; 39(4):862-876. PubMed ID: 31570789
[TBL] [Abstract] [Full Text] [Related]
15. Modulation of myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors.
Tian M; Tian D; Qiao X; Li J; Zhang L
J Cell Physiol; 2019 Nov; 234(11):21126-21134. PubMed ID: 31037726
[TBL] [Abstract] [Full Text] [Related]
16. The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-myb.
Iness AN; Felthousen J; Ananthapadmanabhan V; Sesay F; Saini S; Guiley KZ; Rubin SM; Dozmorov M; Litovchick L
Oncogene; 2019 Feb; 38(7):1080-1092. PubMed ID: 30206359
[TBL] [Abstract] [Full Text] [Related]
17. The activation of microRNA-520h-associated TGF-β1/c-myb/Smad7 axis promotes epithelial ovarian cancer progression.
Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y
Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641
[TBL] [Abstract] [Full Text] [Related]
18. Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth.
Johnson DN; Furtado LV; Long BC; Zhen CJ; Wurst M; Mujacic I; Kadri S; Segal JP; Antic T; Cipriani NA
Arch Pathol Lab Med; 2018 Jul; 142(7):838-850. PubMed ID: 29582677
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathologic features and prognostic implications of mybL2 protein expression in pancreatic ductal adenocarcinoma.
Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
[TBL] [Abstract] [Full Text] [Related]
20. myb, CD117 and SOX-10 expression in cutaneous adnexal tumors.
Evangelista MT; North JP
J Cutan Pathol; 2017 May; 44(5):444-450. PubMed ID: 28098399
[TBL] [Abstract] [Full Text] [Related]
[Next]
